文献速递心脑血管急症消化、代谢与肾脏急症重症综合管理与镇静镇痛

老年患者出院时门诊降压治疗强度的全国回顾性队列研究

Intensification of older adults' outpatient blood pressure treatment at hospital discharge: national retrospective cohort study.
PubMed 文献 · BMJ · 2018-09-12
一句话结论因非心脏疾病住院的老年高血压患者中,14%出院时降压治疗被强化,其中超过一半在入院前血压已控制良好。

该研究为美国退伍军人健康系统的回顾性队列,纳入2011至2013年因非心脏疾病住院的65岁以上高血压患者14915例(中位年龄76岁)。出院时降压治疗强化定义为出院时使用新药或更高剂量降压药。结果显示14%患者出院时治疗被强化,其中1082例(超过一半)入院前门诊血压已控制良好。调整混杂因素后,住院期间血压升高与出院强化降压治疗强烈相关。在入院前血压控制良好的患者中,无住院血压升高者出院强化比例为8%(95%CI 7%至9%),中度升高者为24%(21%至26%),重度升高者为40%(34%至46%)。在获益可能性最小(预期寿命有限、痴呆或转移性恶性肿瘤)和最大(心肌梗死、脑血管病或肾脏疾病史)的患者中,强化比例无差异。

要点

  • 因非心脏疾病住院的65岁以上高血压患者中,14%(2074/14915)出院时降压治疗被强化,其中超过一半(1082例)入院前门诊血压已控制良好。
  • 入院前血压控制良好者中,出院强化比例随住院血压升高而增加:无升高8%(95%CI 7%至9%),中度升高24%(21%至26%),重度升高40%(34%至46%)。
  • 在预期寿命有限、痴呆或转移性恶性肿瘤等最不可能从严格血压控制中获益的患者中,出院强化比例与总体无差异。
  • 在心肌梗死、脑血管病或肾脏疾病史等最可能获益的患者中,出院强化比例亦无差异。

适用人群与场景

  • 美国退伍军人健康系统内,2011至2013年因非心脏疾病住院的65岁及以上高血压患者。

诊断标准与关键阈值

  • 降压治疗强化:出院时使用新药或比入院前更高剂量的降压药物。
  • 入院前门诊血压控制良好:原文定义为门诊血压控制良好,具体阈值原文未报告。
  • 住院血压升高程度分为无升高、中度升高和重度升高,具体阈值原文未报告。

研究设计与关键结果

  • 回顾性队列研究,纳入14915例老年高血压患者(中位年龄76岁,四分位距69至84),9636例(65%)入院前门诊血压控制良好。
  • 2074例(14%)出院时降压治疗被强化,其中1082例(超过一半)入院前血压控制良好。
  • 调整潜在混杂因素后,住院期间血压升高与出院强化降压治疗强烈相关。
  • 入院前血压控制良好者中,无住院血压升高者出院强化比例8%(95%CI 7%至9%),中度升高者24%(21%至26%),重度升高者40%(34%至46%)。
  • 在预期寿命有限、痴呆或转移性恶性肿瘤患者中,以及在心肌梗死、脑血管病或肾脏疾病史患者中,强化比例无差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需要更多关注以减少老年患者从医院过渡到家庭时可能有害的血压过度治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To assess how often older adults admitted to hospital for common non-cardiac conditions were discharged with intensified antihypertensive treatment, and to identify markers of appropriateness for these intensifications.

DESIGN: Retrospective cohort study.

SETTING: US Veterans Administration Health System.

PARTICIPANTS: Patients aged 65 years or over with hypertension admitted to hospital with non-cardiac conditions between 2011 and 2013.

MAIN OUTCOME MEASURES: Intensification of antihypertensive treatment, defined as receiving a new or higher dose antihypertensive agent at discharge compared with drugs used before admission. Hierarchical logistic regression analyses were used to control for characteristics of patients and hospitals.

RESULTS: Among 14 915 older adults (median age 76, interquartile range 69-84), 9636 (65%) had well controlled outpatient blood pressure before hospital admission. Overall, 2074 (14%) patients were discharged with intensified antihypertensive treatment, more than half of whom (1082) had well controlled blood pressure before admission. After adjustment for potential confounders, elevated inpatient blood pressure was strongly associated with being discharged on intensified antihypertensive regimens. Among patients with previously well controlled outpatient blood pressure, 8% (95% confidence interval 7% to 9%) of patients without elevated inpatient blood pressure, 24% (21% to 26%) of patients with moderately elevated inpatient blood pressure, and 40% (34% to 46%) of patients with severely elevated inpatient blood pressure were discharged with intensified antihypertensive regimens. No differences were seen in rates of intensification among patients least likely to benefit from tight blood pressure control (limited life expectancy, dementia, or metastatic malignancy), nor in those most likely to benefit (history of myocardial infarction, cerebrovascular disease, or renal disease).

CONCLUSIONS: One in seven older adults admitted to hospital for common non-cardiac conditions were discharged with intensified antihypertensive treatment. More than half of intensifications occurred in patients with previously well controlled outpatient blood pressure. More attention is needed to reduce potentially harmful overtreatment of blood pressure as older adults transition from hospital to home.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Anderson TS, Wray CM, Jing B, et al. Intensification of older adults' outpatient blood pressure treatment at hospital discharge: national retrospective cohort study. BMJ. 2018. PMID: 30209052. doi:10.1136/bmj.k3503

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。